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a b s t r a c t
Regulatory T cells (Tregs) attenuate lesion severity and disease after HSV ocular or genital infection, but
their role in cutaneous infection remains unclear. Treg depletion (anti-CD25 mAb in C57BL/6 mice or
diphtheria toxin (DT) in DEREG mice) prior to tk-deﬁcient HSV-2 ﬂank infection signiﬁcantly decreased
skin lesion severity, granulocyte receptor-1(Gr-1þ) cell number, and chemokine (KC) expression in the
secondary skin, but signiﬁcantly increased immune effectors and chemokine expression (MCP-1, KC,
VEGF-A) in the draining LN, and activated, interferon-γ producing CD8þT cells in the ganglia. Treg
depletion also signiﬁcantly reduced HSV-2 DNA in the ganglia. Thus, Tregs increase the severity of
recurrent skin lesions, and differentially alter chemokine expression and immune effector homing in the
skin and LN after cutaneous infection, and limit CD8þ T cell responses in the ganglia. Our data suggests
that effects of Treg manipulation on recurrent herpes lesions should be considered when developing Treg
mediated therapeutics.
Crown Copyright & 2013 Published by Elsevier Inc. All rights reserved.
Introduction
Herpes simplex virus (HSV) continues to be a major cause of
mortality and morbidity, especially in the immunocompromised
(Field and Vere Hodge, 2013). Understanding the immunological
mechanisms that govern protective antiviral immunity and disease
at the sites of HSV entry are critical to the development of immu-
notherapeutics and vaccines (Lee and Ashkar, 2012). The skin is the
major physical barrier against HSV entry via muco-epithelium breaks,
where it encounters a variety of cutaneous immune cells, including
epithelial Langerhans cells (LC), and rapidly establishes neuronal
latency. Both residential and inﬁltrating cells, such as macrophages,
neutrophils, Gr-1þ cells, NK cells, dendritic epidermal T cells (DETCs),
and T lymphocytes play a critical role in eliminating HSV infection
from the skin (Wojtasiak et al., 2010a; Loser et al., 2004). We have
recently found that HSV can infect γδTCR þT cells in the murine skin
shortly after inoculation and prior to infection of LCs (Puttur et al.,
2010). In this study we evaluate the role of Tregs cells in the
pathogenesis of cutaneous HSV disease using the ﬂank skin
infection model.
CD4þCD25þFoxp3þT cells are natural Tregs that control auto-
immunity and suppress effector T cell immune responses. They
play an indispensible role in immune homeostasis (Josefowicz
et al., 2012; Sakaguchi, 2004; Sehrawat and Rouse, 2011) and have
been shown to inﬂuence the outcome of infection in different
animal models using different viruses (Maizels and Smith, 2011).
Previous murine studies, including from our own laboratory, have
demonstrated different outcomes after HSV infection and Treg
modulation by depletion using anti-CD25 mAb (PC61), (Suvas
et al., 2003; Fernandez et al., 2008) or DT in mice (Lund et al.,
2008; Veiga-Parga et al., 2012). Treg depletion using DT in DTR
mice caused accelerated fatal disease from genital HSV-2 infection
associated with increased virus in the central nervous system and
delayed effector recruitment to genital mucosa despite augmented
effector responses in the LN (Lund et al., 2008). Treg depletion in
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DT-DEREG mice was also observed to increase lesion severity after
ocular HSV-1 infection (Veiga-Parga et al., 2012). In contrast, Ab
mediated Treg depleted mice showed enhanced immunity after
subcutaneous (footpad) HSV infection with increased clearance of
virus from the footpad (Suvas et al., 2003), LN and brain
(Fernandez et al., 2008). Thus, the effect of Tregs on the outcome
of HSV disease and immunity varies with the method of HSV entry
and Treg manipulation strategy. Subcutaneous infection, however,
bypasses immune effectors in the outermost layers of the skin
such as LC and γδT cells, and does not mimic the natural route of
skin infection in humans (i.e. through breaks in the epithelium). To
date, the effect of Treg depletion on immunity and disease after
cutaneous HSV infection is unknown.
Tregs share a reciprocal developmental pathway with Th17
cells, a novel lineage of CD4þT cells expressing interleukin 17
(IL-17), and mediating inﬂammation during infection and auto-
immune conditions (Bettelli et al., 2006). HSV skin infections elicit
inﬂammation and may potentially enhance Th17 cells. Recently, it
has been reported in mice that IL-17 producing cells play a
prominent role in HSV induced immunopathology and inﬂamma-
tion of cornea (Suryawanshi et al., 2011) and genital mucosa (Kim
et al., 2012). Therefore the role of Th17 cells along with Tregs in
cutaneous HSV immunity is also of interest.
The skin of the male genitalia is a common site of entry of HSV-
2. In this study we used the murine ﬂank skin infection model to
evaluate the effect of Treg depletion on cutaneous HSV-2 disease.
We used two Treg depletion strategies, anti-CD25 mAb (PC61) in
C57BL/6 mice and/or DT in DEREG mice, to evaluate the contribu-
tion of these cells to cutaneous HSV immunity and disease.
Results
Cutaneous tk-deﬁcient HSV-2 infection induces mild non-lethal
zosteriform skin disease in contrast to wt HSV-2
The zosteriform skin model in C57BL/6 mice has been exten-
sively characterized for cutaneous HSV-1 infection (van Lint et al.,
2004) but not for HSV-2 disease. Therefore, for our cutaneous
model of HSV-2 infection, adult C57BL/6 mice were infected with
either wt HSV-2 virus (strain 186) or replication competent tk-
deﬁcient HSV-2 virus (186ΔKpn) using the skin ﬂank method as
reported (Simmons and Nash, 1984). Mice were scored for skin
lesion severity (modiﬁed from (van Lint et al., 2004)). Mice
infected with 1105 PFU/mouse of wt HSV-2 virus developed
severe zosteriform disease at primary and secondary skin sites by
day 6 p.i. (Fig. 1) with signs of CNS spread by day 8 p.i. Cutaneous
lesions were observed after infection with 5106 PFU/mouse of
tk-deﬁcient HSV-2 but not at doses less than this (not shown).
Similarly, ﬂank infection with non-lethal lower doses of wt-HSV-2
(o104 PFU/mouse) did not consistently induce zosteriform
lesions, and so could not be used for this purpose. Lesions from
the tk-deﬁcient HSV-2 virus developed in a similar time frame to
wt HSV-2, but were signiﬁcantly milder at the time of peak lesion
scores (i.e. day 8 p.i.) at both primary and secondary sites (wt vs.
tk-deﬁcient, po0.05, Wilcoxon signed rank test, n¼10) with
complete resolution of vesicles by day 28 p.i. (Fig. 1A and B). To
conﬁrm the differences in skin lesions between wt and tk-deﬁcient
HSV-2 viruses, histological analyses of skin tissues were carried out
using H&E (Fig. 1C). Compared to intact skin, the trauma of
scariﬁcation alone induced mild inﬂammation in the skin of mock
controls (i.e. mice that had been scariﬁed after hair removal but not
infected with HSV). In contrast, skin at both the primary and
secondary sites of wt infected mice showed severe inﬂammation
throughout all layers of the skin, with dense inﬂammatory inﬁltrat-
ing cells, ulceration, epidermal loss and destruction of epidermis
and dermis. A similar, but less dense inﬂammatory inﬁltration was
observed after infectionwith tk-deﬁcient HSV-2. Thus cutaneous tk-
deﬁcient HSV-2 infection induces mild non-lethal zosteriform skin
disease in contrast to wt HSV-2 virus and will be the model used in
this paper to study time points beyond day 8 p.i.
There is early recruitment of Th17 cells to the skin and LN post
tk-deﬁcient HSV-2 infection and a late, sustained increase
in CD4þFoxp3þT cells in the LN
Th17 cells play an important role in immunopathology and
adaptive immunity and share a reciprocal developmental pathway
with Tregs (Bettelli et al., 2006). Their involvement in ocular HSV-
1 infection has been recently reported (Suryawanshi et al., 2011),
but their role in the cutaneous response to HSV-2 has not been
well deﬁned. Recruitment of total CD4þT cells, CD4þFoxp3þcells
(Tregs) CD4þ IL-17þ cells (Th17 cells) and CD4þ IFN-γþ cells into
the site of infection (primary skin) and the site of activation
(draining LN) were determined after infection with wt HSV-2
virus (to day 8 p.i.) or with tk-deﬁcient HSV-2 (to day 28 p.i.) by
ﬂow cytometry analysis. Both wt and tk-deﬁcient HSV-2 viruses
signiﬁcantly increased the total number of CD4þT cells in the skin
and LN at selected times p.i. compared to Mock or Intact skin
controls (Fig. 2A). Peak CD4þT cell responses were observed at day
6 p.i for both viruses at both sites (po0.001, HSV-2 wt or tk-
deﬁcient vs. Mock, Mann Whitney U T test, n¼10–12). Of note,
the signiﬁcant increase in CD4þT cells in the draining LN in
tk-deﬁcient HSV-2 infected mice was sustained up to day 28
p.i. (po0.001, Mann Whitney U T test, n¼8–12) (Fig. 2A and B).
A signiﬁcant increase in Th17þ cells in the skin and LN was also
observed at day 6 and 8 p.i. after wt infection and at day 6 p.i. after
tk infection but not thereafter (Fig. 2A and B), (po0.001, Mann
Whitney U T test, n¼10–12). A small, signiﬁcant increase in Tregs
was observed in the skin of wt HSV and tk-deﬁcient HSV infected
mice compared to controls at day 6 p.i. (po0.05, Mann Whitney U
T test, n¼10) (Fig. 2A and B). A signiﬁcant 3-fold increase in Tregs
was observed in the LN of wt HSV-2 infected mice on day 8 p.i.
compared to mock and intact skin controls. Strikingly, a sustained
increase in the Treg population was observed in the draining LN of
tk-deﬁcient mice from day 6 to 28 compared to controls,
(po0.001, Mann Whitney U T test, n¼46–50) (Fig. 2A and B). A
signiﬁcant increase in CD4þ IFN-γþ expressing T cells was
observed in the LN of tk-deﬁcient HSV-2 infected mice alone
compared to Mock infected controls on day 6 alone (po0.001,
Mann Whitney U Test, n¼10–12) (Fig. 2A). Thus, there is an early
inﬂux of CD4þ Th17 cells and Tregs into the skin and LN after
infection with wt and tk-deﬁcient HSV-2 viruses, and a late
sustained Treg response in the draining LN with tk-deﬁcient
HSV-2, that is evident even after the resolution of skin vesicles.
Treg depletion signiﬁcantly decreases skin lesion severity from
ganglionic viral spread post tk-deﬁcient HSV-2 infection
To assess the biological signiﬁcance of the increased Tregs in
the LN post cutaneous tk-deﬁcient HSV-2 infection, we depleted
Tregs and scored for severity of herpetic cutaneous disease. Tregs
were depleted using one of two methods either in C57BL/6 adult
mice, using anti-CD25 mAb (PC61) 3days prior to HSV infection or
DT treatment in DEREG mice (Lahl et al., 2007), DT induced
toxicity limited detailed studies using this strategy. Treg depletion
by either method was not observed to alter mean lesion scores at
the primary skin of HSV infected mice (Fig. 3A). In contrast, Treg
depletion signiﬁcantly decreased the severity of HSV cutaneous
disease at the secondary skin at day 8–10 p.i. after depletion with
anti-CD25 mAb (PC61) (po0.05, Wilcoxon signed rank test,
n¼10–16), and even more strikingly at day 6 and 8 p.i. after DT
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injection in DEREG mice (Fig. 3A), (po0.001, Wilcoxon signed
rank test, n¼16).
To substantiate these ﬁndings we undertook H&E staining of
skin sections from HSV infected mice and controls at day 8 p.i.
(Fig. 3B). For this, mice were treated with anti-CD25 mAb (PC61) to
deplete Tregs (No Tregs) or with isotype control alone (Tregs), then
infected with tk-deﬁcient HSV-2 or PBS alone (Mock). Histological
appearances of the skin at the primary skin were similar in both
Fig. 1. Skin disease after murine zosteriform infection using wt and replication competent tk-deﬁcient HSV-2 infection. C57BL/6 mice were scariﬁed on the left ﬂank after
hair removal, then topically infected with wt HSV-2 (strain 186; 1105 PFU/mouse) or tk-deﬁcient HSV-2 (186ΔKpn; 5106 PFU/mouse) viruses, or mock infected with PBS.
(A) Skin lesion scores (0–5) at the P—primary skin (site of infection) and the S—secondary skin (site of ganglionic spread) were recorded at times shown using modiﬁcation of
published schema (van Lint et al., 2004) i.e. 0—no lesion; 1—redness or swelling; 2—individual vesicle formation; 3—coalesced and/or ulcerated vesicles; 4—severe ulceration
across the dermatome; 5—necrosis. Shown are individual skin lesion scores with group mean (7SEM) at selected times for wt and tk-deﬁcient HSV-2 viruses (wt vs. tk-
deﬁcient, po0.05, Wilcoxon signed rank test, n¼4–6 mice/time point/virus). Data are from one of four experiments with similar results. (B) Representative photographs
depicting progression of zosteriform disease at both primary and secondary skin sites post wt HSV-2 or tk-deﬁcient HSV-2 virus infection. (C) Photographs of H&E stained
skin (10 ) from primary and secondary sites at day 8 p.i. of wt or tk-deﬁcient HSV-2 infected mice. Also shown are skin samples from mice that have been scariﬁed and
mock infected with PBS alone (Mock), or not scariﬁed, but with hair removal alone (Intact skin).
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groups of infected mice (not shown). Besides the skin lesion
scores, we observed reduced inﬂux of inﬂammatory cells into
the skin at the secondary sites of depleted HSV infected mice. Thus
Treg depletion prior to infection signiﬁcantly decreases the sever-
ity score of HSV skin lesions from secondary skin (i.e. virus coming
from ganglia).
Treg depletion is associated with decreased Gr-1þ cell inﬁltration into
the secondary skin site after cutaneous HSV-2 infection
To further study the effect of Tregs on skin inﬂammation after
cutaneous HSV-2 infection, we examined the immunophenotype
of cells in the skin tissues. The full thickness skin (epidermis and
dermis) of both the primary skin (site of infection) and secondary
skin (site of ganglionic recurrence) were analysed on day 8 p.i.
using ﬂow cytometry for the composition (percentage, number
and proportion) of inﬁltrating T cells (CD45þCD3þ) and non-T
cells (CD45þ CD3).
Infection signiﬁcantly increased the number of T cells (CD45þ
CD3þ cells) in both the primary and secondary skin (Fig. 4A and B)
(po0.05, HSV vs Mock, Mann Whitney U test, n¼12–16) at day
8 p.i. The magnitude of the immune cell inﬁltration into the
secondary skin after infection was less than at the primary skin. Of
all types of T cells analyzed (CD4þ , CD8þ , γδΤCRþ), the γδTCR þT
cells were the major T cell type in HSV infected skin and were
signiﬁcantly increased in both the primary and secondary skin in
infected mice compared to the mock (po0.05, HSV vs. Mock,
Mann Whitney U test, n¼12–16). However, depletion of Tregs did
not alter the magnitude or phenotype of T cell inﬁltration into the
skin. Similar results were observed using the DT-DEREG depletion
strategy prior to HSV infection (not shown).
Interestingly, Treg depletion did alter the phenotype of some
inﬂammatory cells at the secondary skin (Fig. 4A, B and D).
Fig. 2. Tk-deﬁcient HSV-2 induces early Th-17 response and late, sustained Treg responses in draining LN. C57BL/6 mice were scariﬁed and topically infected with wt HSV-2
(strain 186; 1105 PFU/mouse) or tk-deﬁcient HSV-2 (186ΔKpn; 5106 PFU/mouse) viruses, mock infected with PBS or left untreated (Intact skin). Primary skin and LN
were harvested at times from day 1–8 p.i. for wt virus and day′s 1–28 p.i. for tk-deﬁcient HSV-2. Skin was digested with collagenase, skin and draining LN cells were made
into single cell suspension, then ﬁxed, blocked, permeabilized, stained for surface CD4þT cells and intracellular IL-17, Foxp3, IFN-γþ and analyzed by ﬂow cytometry after
gating on viable CD3þ cells. Isotype controls were used for gating for all stains. (A) Shown are mean7SEM cell number of total CD4þ , CD4þ IL-17þ , CD4þFoxp3þ and CD4þ
IFN-γþ cells. (B) Shown are representative FACS plots of CD4þT cell, IL-17 expression at day 6 p.i. in LN and skin, and Foxp3 expression at days 6 and 28 p.i. in the LN alone
fromMock and tk-deﬁcient HSV-2 infected mice. Data are from one of two experiments with similar results, (*po0.05, **po0.001 Mock versus infected by Mann Whitney U
test, n¼8–12).
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Staining of CD3CD45þ cells for markers of NKþ , CDllcþ DC and
Gr-1þ cells, revealed that while DC were the major innate effectors
in HSV infected skin at day 8 p.i. in both groups of mice, Treg
depletion signiﬁcantly decreased the number (Fig. 4B) and propor-
tion (Fig. 4D) of Gr-1þ cells at the secondary skin in infected mice
(570.8% vs. 1373.5% HSV-2 No Tregs vs. Tregs); po0.05, Mann
Whitney U test, n¼12–16). The phenotype of these Gr1þ cells was
CD11bþ , CD11c , F4/80 , NK1.1 suggesting that they were
neutrophils and not macrophages (data not shown). To conﬁrm
the presence of increased Gr-1þ cells in the secondary skin we
performed immunohistochemistry (Fig. 4C). Numerous Gr-1þ cells
were observed in the dermis of HSV infected mice with Tregs, but
not after Treg depletion. Thus Treg depletion reduces Gr-1þ cell
inﬁltration at the secondary site after cutaneous HSV-2 infection.
To test if Gr-1þ cells in the secondary skin of Treg sufﬁcient
mice were implicated in the enhanced severity of HSV cutaneous
disease at this site, mice were depleted of Gr1þ cells by mAB
(RB6–8C5) or left untreated, infected with tk-deﬁcient HSV-2 virus
then scored for cutaneous disease as before. Skin lesion scores of
HSV infected Treg sufﬁcient mice were the same as observed in
earlier experiments (not shown). Gr-1þ depletion signiﬁcantly
increased HSV lesion severity from days 8 to 14 in both the
primary and secondary skin compared to untreated mice (data
not shown) consistent with previous observations (Wojtasiak
et al., 2010a). This suggests that the presence of Gr1þ cells in
the secondary skin are not directly implicated in the formation of
enhanced herpetic lesions at this site. However, the enhanced
lesion severity induced by RB6-8C5 treatment could be due to
depletion of Gr1þ cells at other sites and/or of Gr1þ populations
other than neutrophils as has been reported elsewhere (Wojtasiak
et al., 2010a).
Treg depletion prior to HSV-2 infection signiﬁcantly increases
innate and adaptive effectors in the draining LN and activated,
IFN-γþ producing CD8þT cells in the ganglia
To characterize the effect of Treg depletion in the LN and
ganglia post HSV-2 ﬂank skin infection, mice were depleted of
Tregs by Ab depletion before HSV infection, and cells from LN and
ganglia (ipsilateral 8–12 dorsal root ganglia (DRG) analysed by
ﬂow cytometry at day 8 p.i. as above (Fig. 5). HSV signiﬁcantly
increased the number of all CD45þcells, including T cells (CD4þ ,
CD8þ , and γδTCRþT cells) and non-T cells (NKþ , CD11cþ DC and
Gr-1þ cells) in the LN at day 8 p.i. compared to intact (naive) and
mock mice (po0.05, HSV vs. Mock, Mann Whitney U test, n¼10–
12), which were further increased by Treg depletion (po0.05, HSV
Treg vs. HSV No Treg, Mann Whitney U test, n¼10–12) (Fig. 5A).
HSV infection also signiﬁcantly increased the inﬁltration of CD45þ
cells into the ganglia (Fig. 5B) but in contrast to the LN, these were
mostly T cells (CD45þCD3þ cells) (po0.001, Mann Whitney U
test, n¼10–12) that included CD4þ , CD8þ and of γδTCR þT cells.
Treg depletion prior to HSV infection caused a signiﬁcant increase
in the number of CD8þ T cells alone in the ganglia (HSV No Tregs
vs. HSV Tregs; po0.05, Mann Whitney U test, n¼10–12). This
observation was conﬁrmed in DEREG mice (data not shown).
Using PC61 depletion strategies, T cells from the primary and
secondary skin, LN and ganglia were then examined for intracel-
lular IFNγ expression at day 8 p.i. (data not shown). No signiﬁcant
differences in CD4þ and CD8þ IFNγ expression was observed
between Treg depleted and sufﬁcient HSV infected mice in both
the primary and secondary skin (data not shown). Treg depletion
signiﬁcantly increased the number of CD4þ and activated (CD25þ)
and IFNγ producing CD8þ T cells in the LN (Fig. 6A) (HSV Treg vs.
HSV No Treg; po0.05, Mann Whitney U test, n¼10–12), and
activated, CD8þ IFNγþ T cells in the ganglia (Fig. 6B) (HSV Treg vs.
HSV No Treg; po0.05, Mann Whitney U test, n¼10–12). Together
this data suggests that Tregs suppress not only T effector responses
in the LN but also suppress the CD8þ T cell responses to HSV in the
ganglia.
Treg depletion prior to HSV infection reduces KC expression
in the secondary skin and increases inﬂammatory chemokine
expression in the draining LN
Keratinocyte-derived chemokine (KC/CXCL1) and monocyte
chemo attractant protein-1 (MCP-1/CCL2) have been shown to
be involved in neutrophil recruitment to the skin after HSV
infection (Wojtasiak et al., 2010a), and vascular endothelial growth
factor A (VEGF-A) expression is increased in the cornea after HSV
ocular infection (Suryawanshi et al., 2011). Therefore we next
tested if the effect of Treg depletion on Gr-1þ cell trafﬁcking to
and inﬂammation in the secondary skin was associated with
changes in expression of these factors in the secondary skin and
Fig. 3. Treg depletion attenuates lesion severity in the secondary skin site post tk-
deﬁcient HSV-2 infection. C57BL/6 mice were depleted of Tregs (No Tregs) by
treatment with either anti-CD25 mAb (PC61) or DT in DEREG mice prior to ﬂank
infection with tk-deﬁcient HSV-2 (HSV), or mock infected with PBS (Mock). Control
mice were treated with isotype mAb or no DT respectively prior to infection (Tregs).
(A) Mice were scored for skin lesion severity at the primary and secondary skin at
selected times as per schema in Fig. 1. Shown are mean scores7SEM from each
group (*po0.05 and **po0.001, HSV Treg vs. HSV No Treg, Wilcoxon signed rank
test, n¼10–16/group/intervention). Data are from one of two separate experiments
with similar results. (B) Shown are representative photographs (10 ) of H&E
stained secondary skin at day 8 p.i. with tk-deﬁcient HSV-2 with or without Treg
depletion (Treg vs. No Treg, respectively).
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LN. For this, mRNA expression of MCP-1(CCL2), KC and VEGFA
were determined in the secondary skin and LN at days 4 and 8 p.i.
by RT-PCR in HSV infected Treg depleted and sufﬁcient mice, and
compared relative to expression in mock controls (Fig. 7A). We
observed that HSV-2 signiﬁcantly increased expression of MCP-1
(CCL2), KC and VEGF-A in the skin at day 4 p.i. and MCP-1(CCL2)
alone at day 8 p.i. compared to mock controls. In the LN, HSV-2
infection signiﬁcantly increased these factors relative to mock
controls at both times measured. Treg depletion reduced KC
expression in the secondary skin at day 4 alone compared to Treg
sufﬁcient mice, but did not alter MCP-1(CCL2) or VEGF-A expres-
sion post HSV infection. In contrast MCP-1(CCL2), KC, and VEGF-A
expression were increased in the LN in HSV infected mice by Treg
depletion at both days 4 (KC, VEGF-A) and day 8 p.i. (MCP-1, KC,
VEGF-A) (HSV Treg vs. HSV No Treg; po0.05, Mann Whitney U
test, n¼6). Thus, Treg depletion alters the chemokine gradient
between the secondary skin and LN after zosteriform HSV infec-
tion. To further explore the mechanism by which Tregs increase
disease severity in the secondary skin, we next determined the
expression IFNγ and IL-17 by Tregs in the secondary skin and LN at
day 8p.i. after HSV compared to mock controls (Fig. 7B). Expres-
sion of these cytokines by Tregs in the skin was not increased
signiﬁcantly by HSV, whereas Treg IFNγ expression in the LN was
signiﬁcantly increased (Mock vs. HSV; po0.05, Mann Whitney U
test, n¼10–12). This suggests that Tregs develop an effector
phenotype in the LN after HSV-2 infection.
Treg depletion prior to HSV-2 infection reduces HSV-2 DNA copy
number in the ganglia at day 4 p.i.
We next determined the effect of Treg depletion on the titer of
infectious HSV-2 and viral DNA load in the secondary skin, LN and
ganglia (ipsilateral DRGs T8-12) at days 4 and 8 p.i. using tk-
deﬁcient HSV-2 virus. No infectious virus was detected by stan-
dard plaque assay in the secondary skin or LN at either time or in
the ganglia at day 8 in the presence or absence of Tregs (not
shown). In 30% of mice with Tregs, low titers of infectious virus
(5 PFU/mice ganglia) were detected on day 4 only. Viral DNA in the
Fig. 4. Immunophenotype primary and secondary skin after tk-deﬁcient HSV-2 infection with or without Treg depletion. C57BL/6 mice were depleted of Tregs by treatment
with anti-CD25 mAb (PC61) (No Tregs), or treated with isotype control alone (Tregs), prior to ﬂank infection with tk-deﬁcient HSV-2 (HSV-2), or mock infection with PBS
(Mock). Shown also are analyses of skin from mice treated with hair removal alone (Intact). Skin was harvested on day 8 p.i. from the site of infection (primary skin) and the
site of ganglionic spread (secondary skin) (n¼5–8mice/intervention). Single cell suspensions of full thickness skin (epidermis and dermis) were prepared by collagenase
digestion then stained with ﬂuorochrome conjugated mAbs to CD45þ , CD3þ , CD4þ , CD8þ , γδTCRþ , NK1.1þ , Gr-1þ , and CDllcþ . Flow cytometry analysis was performed
using LSRII machine (BD Bioscience) and data analyzed by Flow Jo, Cell quest and Prism software. Shown are mean cell numbers7SEM of (A) Primary skin and (B) secondary
skin (*po0.05, HSV Treg vs. HSV No Treg, Mann Whitney U test (n¼5–8 mice/intervention). (C) Representative photographs (10 ) of IHC of inﬁltrating Gr-1þ cells from
secondary skin at day 8 p.i. with tk- deﬁcient HSV-2 with or without Treg depletion (Tregs vs. No Tregs, respectively). (D) Representative ﬂow cytometry plots at day 8 p.i
with mean percentage7SEM of CD45þCD3Gr-1þ cells in the secondary skin. Data are from one of two experiments with similar results, (*po0.05, HSV Treg vs. HSV No
Treg, Mann Whitney U test, n¼12–16).
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LN and secondary skin was below the level of detection in infected
mice with or without Tregs at both times (data not shown). In
contrast, viral DNA was detected in the ganglia of infected mice at
both days 4 and 8 p.i. (Fig. 8), with the copy number being less at
the later time. Of note, Treg depletion by either strategy signiﬁ-
cantly reduced the viral DNA copy number by approximately a log
at day 4 p.i. alone. (HSV Treg vs. HSV No Treg, po0.05 Mann
Whitney U test, n¼10). Thus, Treg depletion decreases the amount
of viral DNA in the ganglia shortly after infection.
Discussion
HSV-2 is an important cause of genital herpes including sites
such as penile skin, yet the Treg response to this virus in the skin is
not well described. In this study we used a murine ﬂank skin HSV-
2 infection model to address the role of Tregs in the resolution of
herpetic lesions in the skin. We demonstrate for the ﬁrst time that
Treg depletion attenuates the severity of cutaneous lesions at the
site of ganglionic spread of virus in contrast to effects observed in
the vagina or the cornea after genital (Lund et al., 2008) or ocular
infection (Veiga-Parga et al., 2012), respectively. Depletion of Tregs
prior to cutaneous infection resulted in reduced Gr-1þ neutrophils
in the secondary skin, increased immune effectors in the LN,
increased CD8þT cells and reduced viral DNA in the ganglia, and
altered the inﬂammatory chemokine (KC) between the skin and
draining LN.
The zosteriform murine model of HSV disease has been used
extensively to study HSV-1 immune responses to peripheral
immunity (Weeks et al., 2001; Kramer et al., 2003; Eidsmo et al.,
2012; Lubinski et al., 2011; Abendroth et al., 2000) as it emulates
naturally occurring skin HSV infection in humans (Simmons and
Nash, 1984; Sydiskis and Schultz, 1965). This model provides new
information to our earlier Treg subcutaneous infection studies
(Fernandez et al., 2008). Here we report for the ﬁrst time on the
progression and resolution of disease after Treg depletion and
infection through the epithelium, at the primary skin (site of
entry), secondary skin (site of ganglionic spread), and ganglia
(neuronal innervating site) in addition to the draining LN (site of
activation). Published reports on HSV-2 ﬂank infection have been
limited to vaccination studies (Wang et al., 2010, 2008). We report
here that cutaneous disease using tk-deﬁcient HSV-2 virus ﬂank
infection was less severe than wt HSV-2 infection and did not
result in lethal CNS disease. Although HSV-1 tk-deleted strains
typically do not replicate in sensory ganglia (Kosz-Vnenchak et al.,
1993; Thompson and Sawtell 2000); infectious virus has been
isolated from the trigeminal ganglia after infection with HSV-2TK-
deﬁcient strains in HSV-2 strain 186 background (Jones et al.,
2000; Evans and Jones, 2005), hence the development of lesions at
the site of ganglionic spread after infection with the HSV-2 tk-
deﬁcient virus was not unexpected. As this virus contains only
a small, 213 bp deletion, it is possible that the TK cellular
complementation activity has been retained. The combination
of a replication competent, neuroattenuated HSV-2 strain that
generates lesions at the secondary site (i.e.non-lethal) made this
virus a useful lesion resolution model for the study of secondary
lesions.
IL-17 producing CD4þ cells (Th-17) have been reported to
mediate inﬂammation during infection whereas Tregs are thought
to limit these responses. IL-17 responses to HSV have been studied
in the eye after HSV keratitis in humans (Maertzdorf et al., 2002),
and after corneal (Maertzdorf et al., 2002; Molesworth-Kenyon
et al., 2008) and genital HSV infection in mice (Kim et al., 2012).
A biphasic IL-17 response to HSV-1 has been reported in the eye
with γδTCRþT cells being the early source of the cytokine and
CD4þ T cells (Th17 cells) the later source, concordant with the
development of sustained corneal disease (Suryawanshi et al.,
2011). Unlike the ocular model, we did not observe IL-17 produ-
cing γδTCRþT cells or Th17 cells at later times in infected mice.
This is likely because there is lesion resolution in our model rather
than immunopathology. After HSV-2 tk-deﬁcient virus cutaneous
infection we observed early Th17 responses in both the skin and
Fig. 5. Treg depletion increases immune cells in the draining LN and ganglia day 8 post tk-deﬁcient HSV-2 infection. C57BL/6 mice were depleted of Tregs with anti-CD25
mAb (PC61) treatment (No Tregs) or treated with an isotype control (Tregs) prior to ﬂank infection with tk-deﬁcient HSV-2 (HSV-2) or mock infection with PBS (Mock) or
were left untouched as naive mice (Intact). (A) Draining LNs (B) ganglia (ipsi lateral DRGs 8–12) were collected day 8p.i. (n¼5–8 mice/intervention) and stained with
ﬂuorochrome conjugated mAbs to CD45þ , CD3þ , CD4þ , CD8þ , γδTCRþ , NK1.1þ , Gr-1þ , and CDllcþ and analyzed by ﬂow cytometry. Shown are mean cell number7SEM
(*po0.05, Mann Whitney U test in n¼10–12 mice/group). Data are from one of three separate experiments with similar results.
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Fig. 6. Treg depletion increases the number of IFNγ expressing T effector cells in the LN and CD8þ IFNγþ ganglia day 8p.i. of HSV infected mice. C57BL/6 mice were depleted
of Tregs by treatment with anti-CD25 mAb (PC61) (No Tregs), or treated with isotype control alone (Tregs), prior to ﬂank infection with tk-deﬁcient HSV-2, (HSV-2) or mock
infection with PBS (Mock). Shown also are samples from uninfected mice treated with hair removal alone (Intact). Primary skin, secondary skin, draining LN and ganglia (ipsi
lateral DRGs 8–12) were harvested on day 8 p.i., made into single cell suspension (n¼5–6 mice/intervention) and stained with ﬂuorochrome conjugated mAbs for CD45þ ,
CD3þ , CD4þ , CD8þ , IFN γþand analyzed by ﬂow cytometry. Shown are mean cell number of CD4þ IFN γþand CD8þ IFN γþT cells at day 8 p.i in the LN (A) and ganglia (B)
7SEM *po0.05, Mann Whitney U test in (n¼10–12/group). Representative ﬂow cytometry plots indicating percentage (Mean7SEM) of IFN γþCD4þ , CD25þ CD8þ and IFN
γþCD8þT cells at day 8 p.i. in draining LN (C) and ganglia (D). Shown are mean cell number7SEM (*po0.05, Mann Whitney U test in n¼10–12 mice/group). Data are from
one of two separate experiments with similar results.
M.A. Fernandez et al. / Virology 447 (2013) 9–2016
the LN, and a late, sustained increase in Tregs in the LN suggesting
a potential role for Tregs in the resolution of skin lesions during
HSV infection. The mechanism of this persistence is unclear, but a
similar persistence of CD4þT cells has been reported in the LN
after HSV infection in mice cornea (Veiga-Parga et al., 2011) and in
human skin even after viral clearance and epithelial healing (Zhu
et al., 2007, 2009).
Depletion of natural Tregs by mAb depletion of CD25þ cells
prior to infection in murine models has been reported to augment
effector responses to HSV in the draining LN by us and others
(Suvas et al., 2003,2004; Fernandez et al., 2008). Given that this
method may also deplete other CD25þ cells, in this study, we used
DT treatment of DEREG mice as an alternative method of Treg
depletion. This strategy has also been used in other viral infection
models (Loebbermann et al., 2012; Reuter et al., 2012; Stross et al.,
2012; Abel et al., 2012) including genital (intra vaginal) HSV-2
(Lund et al., 2008) and HSV-1 ocular (Veiga-Parga et al., 2012)
infections. Our study is the ﬁrst to use DT-DEREG mice to evaluate
the effect of Treg depletion on HSV-2 skin infection. Using either
method, we observed that Treg depletion prior to cutaneous
infection with tk-deﬁcient HSV-2 resulted in milder skin disease
and reduced skin inﬂammation at the site of viral recurrence, and
reduced virus spread to the ganglia. This is opposite to the effect
observed after Treg ablation prior to intra-vaginal HSV-2 infection
where accelerated fatal infection with increased virus spread was
reported (Lund et al., 2008). These differences in disease outcome
could be attributed to the model studied, different route of
infection and the progression of disease and suggests that Tregs
play a different role in cutaneous HSV responses compared to
effects in genital mucosa.
Fig. 7. Treg depletion reduces KC expression in secondary skin and increases inﬂammatory chemokine expression in the LN of HSV infected mice. HSV increases Treg IFN-γ
expression in the LN. C57BL/6 mice were depleted of Tregs by treatment with anti-CD25 mAb (PC61) (No Tregs), or treated with isotype control alone (Tregs), prior to ﬂank
infection with tk-deﬁcient HSV-2, (HSV-2) or mock infection with PBS (Mock). Secondary Skin and LN were harvested in groups of mice at day 4 or day 8 p.i. Cells were lysed,
total mRNA and cDNA prepared and qRT-PCR was performed. (A) Shown are the relative expression7SEM of MCP-1, KC and VEGF-A in the secondary skin and LN of infected
mice (Tregs and No Tregs) standardised to mock controls (relative expression¼1) after normalization to β-actin, (*po0.05, Mann Whitney U test in n¼6 mice/group). The
level of expression of mock control is indicated by the broken horizontal line. To analyze the effector phenotype of Tregs, secondary skin and draining LN were harvested on
day 8 p.i., made into single cell suspensions (n¼5–6 mice/intervention), stained for CD45þ , CD3þ , CD4þ , Foxp3þand IL-17, IFN γþand analyzed by ﬂow cytometry.
(B) Shown are mean cell number of CD4þFoxp3þ IFN γþor CD4þFoxp3þ IL-17þcells at day 8 p.i7SEM *po0.05, Mann Whitney U test in (n¼10–12/group). Data are from
one of two separate experiments with similar results.
Fig. 8. Treg depletion reduces the HSV-2 DNA copy number in the ganglia at day
4 p.i. C57BL/6 mice were depleted by treatment with either anti-CD25 mAb (PC61)
or DT in DEREG mice (HSV (No Tregs), or treated with isotype control alone (Tregs),
prior to ﬂank infection with tk-deﬁcient HSV-2, (HSV-2) or mock infection with PBS
(Mock), or left untouched as naive mice (Intact). Skin, LN and ganglia were
harvested in groups of mice at day 4 or day 8 p.i. HSV-2 DNA copy number was
determined in the ganglia by real time PCR. Shown are Log10 mean viral DNA copy
number7SEM per ganglia sample from mice treated with anti-CD25 mAb (PC61)
or DT in DEREG mice based on the standard curve. Data are from one of two
separate experiments with similar results, (*po0.05; HSV-2 Treg vs. HSV-2 No
Treg, Mann Whitney U test n¼10–12). The lower level of detection of viral DNA is
indicated by the broken horizontal line.
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Trafﬁcking of neutrophil granulocytes into herpetic lesions, and the
importance of neutrophils in resolution of HSV infection has beenwell
described in a number of studies (Wojtasiak et al., 2010a, b;
Molesworth-Kenyon et al., 2012). Here we show that Treg depletion
decreased skin inﬂammation at the site of viral spread from the
ganglia associated with reduced Gr1þ neutrophils at this site. Surpris-
ingly, Gr1þ cell depletion prior to HSV-infection of Treg sufﬁcient mice
increased rather than attenuated lesion severity at both the primary
and secondary sites, consistent with reported effects using the same
mAb (RB6-8C5) before HSV-1 ﬂank infection (Wojtasiak et al., 2010a).
This suggests that Gr1þ neutrophils in isolation are not directly
implicated in the enhanced secondary skin lesion severity observed
in Treg sufﬁcient mice. However, it is also possible that the effect was
masked by depletion of Gr1þ populations other than neutrophils that
have been shown to be important for clearance of HSV (Wojtasiak
et al., 2010b). No other discernible effects of Treg depletion on
immune skin inﬁltrates in HSV infected mice were observed. However,
as our analyses focussed on the day when the maximal effect of
depletion on the severity of skin disease was observed, we cannot
exclude an effect on other cell types at earlier times.
The mechanism(s) and site(s) of Tregs modulation of HSV skin
disease severity are still to be fully elucidated, but our data provide
insight into possible mechanism(s). Tregs may affect Gr-1þ cell
recruitment to the site of ganglionic recurrence by differentially
modulating the chemokine gradient that controls Gr-1 homing to skin
and effector homing from the LN. In support of this, we observed
increased expression of KC, a chemokine important for neutrophil
recruitment in the secondary skin of HSV infected mice in Treg
sufﬁcient mice, coupled with reduced inﬂammatory chemokine
expression in the draining LN. This observation is consistent with
reported effects of Treg depletion in the genital HSV model, where
Tregs have been shown to control effector cell homing between
secondary lymphoid organs through and the vaginal mucosa by
having different effects on chemokine production at each site (Lund
et al., 2008). Bidirectional homing of Tregs between the skin and LN
site of activation has also been shown in skin inﬂammation models
(Matsushima and Takashima, 2010). We also observed an increase in
activated, IFNγ-expressing CD8þT cells in both the draining LN and
ganglia after HSV infection, and a reduction in HSV DNA in the dorsal
root ganglia after Treg depletion. Therefore, Tregs may also increase
disease severity at the site of viral recurrence in our model by limiting
effector responses in the dorsal root ganglia (DRG). The importance of
CD8þ T cells in HSV clearance from sensory ganglia has also been
shown by a number of groups (van Lint et al., 2004; Lang and
Nikolich-Zugich, 2005; Simmons and Tscharke, 1992; St Leger et al.,
2011); and Treg depletion has also been shown to restore CD8þ IFN-
γþT cell trafﬁcking to the brain of vitamin E deﬁcient mice (Sheridan
and Beck, 2009). Tregs may also have modiﬁed disease on the site of
recurrent HSV by effects on innate effectors in the ganglia at earlier
times not studied.
Although antiviral therapies are available to treat HSV disease
there is still a need to develop new anti-herpetic compounds with
different mechanism of action to reduce morbidity and limit
spread. Augmentation of Tregs has been suggested as a potential
immunotherapy (Berod et al., 2012). Our results suggest that Tregs
may enhance cutaneous herpetic recurrence. Therefore, the effects
of Treg manipulation on recurrent HSV disease should be con-
sidered when developing Treg mediated therapeutics.
Methods
Animals and viruses
Female adult C57BL/6 mice, 4–6 weeks of age were purchased
from the Animal Resource Centre (Perth, Australia), acclimatized
and experiments conducted with the approval of the Children′s
Hospital at Westmead and Westmead Hospital Animal Ethics
committees. Mice were ﬂank infected either with 1105 PFU/
mouse of wild type (wt) HSV-2 strain 186synþ-1 (Spang et al.,
1983) or doses of thymidine kinase (TK) deﬁcient HSV-186synþ-1
(186ΔKpn) from 1105 to 5106 PFU/mouse (Jones et al., 2000),
or mock-infected with an equivalent volume of low-endotoxin PBS
(Invitrogen Corporation, Carlsbad, CA). Viruses were propagated
and stored as previously described (Evans and Jones, 2002). The
tk-deﬁcient HSV-2 virus, an attenuated replication competent
virus was kindly provided by David Knipe, Harvard Medical School
(Boston, MA).
Zosteriform abrasion model of HSV-2 infection
To mimic the route of HSV infection in humans we used an
epicutaneous ﬂank scariﬁcation skin infection model as previously
described (Simmons and Nash, 1984; van Lint et al., 2004). Brieﬂy,
mice were anaesthetized, the left ﬂank shaved and depilated
(Nair), then infected topically by applying 10 μl of virus or PBS
within a 2 mm/2 mm area on the ﬂank skin which was scariﬁed 20
times using an 18G needle, and a dressing applied after one for
24 h to facilitate infection. Mice were scored for skin lesion
severity at the primary skin-P (site of infection) and secondary
skin-S (site of spread of virus from the ganglia), from 0 to 5 i.e.
0—no lesion; 1—redness or swelling; 2—individual vesicle forma-
tion; 3—coalesced and/or ulcerated vesicles; 4—severe ulceration;
5—necrosis, (modiﬁed from (van Lint et al., 2004)).
Depletion of Tregs and Gr-1 cells
In vivo depletion of Tregs was achieved using one or two
different depletion strategies standardized to achieve maximum
depletion with minimal toxicity at the time of infection. (1) PC61
depletion: puriﬁed rat anti-mouse CD25 monoclonal IgG1 anti-
body (PC61, Bio Express, West Lebanon, NH) was administered i.p.
into adult mice (0.5–1 mg) three days prior to HSV infection
(Fernandez et al., 2008). Control mice were given an equivalent
dose of a rat IgG isotype antibody. (2) DT-DEREG depletion: To
deplete Foxp3 cells (Tregs), DEREG mice were injected i.p. with DT
(Merck, unnicked from Corynebacterium diphtheriae, catalogue
number 322326), diluted in endotoxin-free PBS, 1 μg daily for
three consecutive days prior to infection (Lahl et al., 2007). The
efﬁciency of depletion was conﬁrmed by ﬂow cytometry using PE
conjugated anti-mouse CD4 and puriﬁed anti-CD25-biotin (7D4)/
streptavidin-APC, and shown to be 490% in blood and ﬂank
draining LN at time of infection for both methods and at day 8 p.i.
(PC61).
Gr-1 depletion was achieved by i.p. injection (0.5 mg in 0.2 ml)
of mAb RB6–8C5 (anti-Ly6G/Ly6C, also known as anti-Gr-1; Bio
Express, West Lebanon, NH) 24 h prior to infection and every 48 h
thereafter as described (Wojtasiak et al., 2010a). Gr1þ cell deple-
tion efﬁciency was 490% in blood and LN at time of infection.
Tissues for analyses, antibodies, intracellular cytokine staining
and ﬂow cytometry
Skin (24 mm) from primary skin-P (dorsal area of left ﬂank)
and secondary skin-S (ventral area of left ﬂank) see Fig. 1B, the
ﬂank draining lymph nodes (LN) and ganglia (ipsilateral 8–12
dorsal root ganglia (DRG)) were harvested at days post infection
(p.i.) and analyzed using ﬂow cytometry. Skin and ganglia were
digested with collagenase 3 mg/ml (30–60 min at 37 1C) or until
digested. Draining LNs were homogenized then made into single
cell suspension. Cells counts were by trypan blue exclusion
method and processed for ﬂow cytometry as described previously
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(Fernandez et al., 2008). Brieﬂy samples from infected, mock
infected controls or intact mice were ﬁrst blocked in PBS contain-
ing 1% Fc block (2.4G2), and normal serum for 30 min at 4 1C.
Surface staining was at 4 1C for 20 min using antibodies obtained
from BD Pharmingen, eBioscience or Biolegend: anti-CD4 FITC
(RM4-5), anti-CD3 APC (145-2C11), anti-mouse/rat Foxp3 PE (FJK-
16s); anti-IL-17 FITC (TC11-18H10.1), anti-CD45 PerCP (30-F11),
anti-CD8 Paciﬁc Blue (53–67), anti-Gr-1 PECy7 (RB6-8C5), anti-
IFNγ FITC (XMG1.2), anti-CD11cAPC (clone-HL3) and anti-γδ TCR
PE (κGL3). Intracellular Foxp3/Th17 staining was done using the PE
anti-mouse/rat Foxp3 staining Kit (eBioscience cat no.72-5775-40).
Brieﬂy cells were surface stained then ﬁxed and permeabilized at
4 1C for 18 h. For IFN-γ intracellular cytokine staining, cells were
ﬁrst restimulated with UV-inactivated wt-HSV2 (strain 186, MOI of
5) for T cell stimulation, at 37 1C, overnight in RPMI1640 (Invitro-
gen Corporation, Carlsbad, CALife Technologies). Brefeldin A (Gol-
giPlug, BD Biosciences) was added to a ﬁnal concentration of 1 μg/
ml for the ﬁnal 4 h of stimulation as previously published
(Fernandez et al., 2008). Cells were then ﬁxed, permeabilized
and stained as for intracellular Foxp3 staining. Data acquired on a
BD LSRII ﬂow cytometer and analyzed using Diva (BD Biosciences,
San Jose, CA) or Flow Jo software (Tri star, USA).
Histological examination
Histology of skin samples was carried out according to Wang
et al. (2012). Tissues were ﬁxed in 10% formalin and embedded in
parafﬁn before staining with H&E, performed by the Department
of Pathology, Westmead Hospital. Immunohistochemistry (IHC)
was performed on frozen OCT sections prepared using CryoStat
machine (Leica). Sections on Polysines slides (Thermo Scientiﬁc)
were dried overnight at room temperature, ﬁxed in acetone (100%)
for 8 min at 4 1C. In order to block endogenous peroxidase activity,
sections were incubated in 0.06% H2O2/PBS buffer for 10 min at
room temperature; some sections were incubated with avidin
biotin-blocking system (Zymed Laboratories), after which all
samples were blocked in 20% normal goat serum/PBS buffer for
20 min. Primary and the second Ab biotinylated rabbit anti-rat Ig
(Dako Cytomation) were used as a three-step staining procedure
in combination with biotinylated rabbit anti-rat Ig as the second-
ary Ab and streptravidin-HPR (Zymed Laboratories) with the two-
step DAB detection system (Sigma-Aldrich). Slides were mounted
(Ultrasound No 4, Fronine) and analysed using Aperio Virtual
microscope. Photographs were taken by Aperio Image Scope
version 11.1.2.760 software.
Standard plaque assay and determination of viral DNA copy number
The titer of infectious HSV-2 in the tissues of infected mice with
and without Tregs was determined by standard plaque assay as
previously reported (Fernandez et al., 2008). In brief dorsal root
ganglia, draining LN and secondary skin were collected from mice
infected with 5106 PFU/mouse of the Tk-negative HSV-
186synþ-1 mutant at days 4 and 8 p.i, and frozen in 0.5 ml of
assay medium (PBS containing 0.1% fetal bovine serum, 0.1%
glucose, and 0.1% CaCl2) at 80 1C. For assay, tissues were thawed
on ice, homogenized using a sterile Kontes pestle, and plated on
Vero cells in duplicate using serial ten-fold dilutions, and infec-
tious titer determined after 48 h by ﬁxing the monolayers with
methanol and staining with 1 Giemsa.
The viral DNA copy number in the tissues of infected mice with
and without Tregs was determined by real-time PCR (Fernandez
et al., 2008). In brief, skin (primary and secondary), draining LN
and ganglia were collected and stored at days 4 or 8 p.i. from mice
infected with the tk-deﬁcient HSV-2 as above. For assay, DNA was
isolated using QIAamp DNA-Mini-Kit (Qiagen) and adjusted to a
constant volume. QPCR, using a real-time PCR machine, ABI PRISM
7700 (PE Applied Biosystems) was used for quantiﬁcation of viral
genomes and copy number using the standard curve method. PCR
mixture contained 0.3 μM primers speciﬁc for HSV ICP8 (Donaghy
et al., 2009) and 0.05 μM Taq Man probe and was cycled for 10 min
at 95 1C, 40 cycles of 15 s/cycle at 95 1C then 1 min at 60 1C. Each
sample was analyzed in triplicate and copy number of viral DNA
calculated using the rotor gene software version 6.1 (Corbett
research).
Chemokine expression
Chemokine expression was analyzed by RT-PCR according to
Veiga-Parga et al. (2012). Cells from secondary skin and draining LN
were lyzed, and total mRNA was extracted using TRIzol LS reagent
(Invitrogen). Total cDNA was made with 0.5–1 mg RNA, using oligo
(dT) primer. Quantitative RT-PCR (qRT-PCR) was performed using
SYBR Green PCR Master Mix (Applied Biosystems). The expression
levels of different molecules were normalized to β-actin, using ΔCt
calculation. Relative expression between control and experimental
groups was calculated using the 2ΔΔCt formula. PCR primers used
were: β-actin: F5′-TCCGTAAAGAATCTCATGCC-3′, R5′-ATCTTCATCCT
CCTAGGAGC-3′; KC: F5′-GTGTTGCCCTCAGGGCC-3′, R5′-GCCTCGCGAC-




The Wilcoxon signed rank test, or the Mann Whitney U test
were used where appropriate to calculate the statistically signiﬁ-
cant differences between samples. A value of po0.05 was con-
sidered signiﬁcant.
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